2022 ICD-10-CM Code E85.9
Amyloidosis, unspecified
Valid for Submission
| ICD-10: | E85.9 |
| Short Description: | Amyloidosis, unspecified |
| Long Description: | Amyloidosis, unspecified |
Code Classification
E85.9 is a billable diagnosis code used to specify a medical diagnosis of amyloidosis, unspecified. The code E85.9 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
The ICD-10-CM code E85.9 might also be used to specify conditions or terms like amyloid myopathy, amyloidosis, dilated cardiomyopathy due to infiltration, dilated cardiomyopathy secondary to amyloidosis, entrapment syndrome due to amyloid , hypothyroidism due to amyloidosis, etc.
Unspecified diagnosis codes like E85.9 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code E85.9 are found in the index:
- - Amyloidosis (generalized) (primary) - E85.9
- - Degeneration, degenerative
- - amyloid - See Also: Amyloidosis; - E85.9
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Amyloid myopathy
- Amyloidosis
- Dilated cardiomyopathy due to infiltration
- Dilated cardiomyopathy secondary to amyloidosis
- Entrapment syndrome due to amyloid
- Hypothyroidism due to amyloidosis
- Hypothyroidism due to infiltrative disease
- Infiltrative cardiomyopathy
- Nephrotic syndrome associated with another disorder
- Nephrotic syndrome in amyloidosis
- Restrictive cardiomyopathy secondary to amyloidosis
- Secondary restrictive cardiomyopathy
Clinical Information
- IMMUNOGLOBULIN LIGHT CHAIN AMYLOIDOSIS-. a nonproliferative disorder of the plasma cell characterized by excessive production and misfolding of immunoglobulin light chains that form insoluble amyloid fibrils see amyloid deposits in various tissues. clinical features include liver failure; multiple myeloma; nephrotic syndrome; restrictive cardiomyopathy and neuropathies.
- AMYLOIDOSIS-. a group of sporadic familial and/or inherited degenerative and infectious disease processes linked by the common theme of abnormal protein folding and deposition of amyloid. as the amyloid deposits enlarge they displace normal tissue structures causing disruption of function. various signs and symptoms depend on the location and size of the deposits.
- AMYLOIDOSIS FAMILIAL-. diseases in which there is a familial pattern of amyloidosis.
- AMYLOID NEUROPATHIES FAMILIAL-. inherited disorders of the peripheral nervous system associated with the deposition of amyloid in nerve tissue. the different clinical types based on symptoms correspond to the presence of a variety of mutations in several different proteins including transthyretin prealbumin; apolipoprotein a i; and gelsolin.
- CEREBRAL AMYLOID ANGIOPATHY FAMILIAL-. a familial disorder marked by amyloid deposits in the walls of small and medium sized blood vessels of cerebral cortex and meninges.
Diagnostic Related Groups - MS-DRG Mapping
The ICD-10 code E85.9 is grouped in the following groups for version MS-DRG V39.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). applicable from 10/01/2021 through 09/30/2022.
| MS-DRG | MS-DRG Title | MCD | Relative Weight |
|---|---|---|---|
| 545 | CONNECTIVE TISSUE DISORDERS WITH MCC | 08 | 2.4995 |
| 546 | CONNECTIVE TISSUE DISORDERS WITH CC | 08 | 1.2066 |
| 547 | CONNECTIVE TISSUE DISORDERS WITHOUT CC/MCC | 08 | 0.833 |
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.
Convert E85.9 to ICD-9 Code
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code E85.9 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.
- 277.30 - Amyloidosis NOS (Approximate Flag)
Information for Patients
Amyloidosis
Amyloidosis occurs when abnormal proteins called amyloids build up and form deposits. The deposits can collect in organs such as the kidney and heart. This can cause the organs to become stiff and unable to work the way they should.
There are three main types of amyloidosis:
- Primary - with no known cause
- Secondary - caused by another disease, including some types of cancer
- Familial - passed down through genes
Symptoms can vary, depending upon which organs are affected. Treatment depends on the type of amyloidosis you have. The goal is to help with symptoms and limit the production of proteins. If another disease is the cause, it needs to be treated.
[Learn More in MedlinePlus]
Code History
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)